Catalent continues to boost biologics offering
Catalent has upgraded its North Carolina, US, sterile development and analytics plant to increase its aseptic fill-finish activities four-fold in a bid to boost its integrated biologics offering.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs